Plasma kynurenic acid/tryptophan ratio: A sensitive and reliable biomarker for the assessment of renal function

Renal Failure

Volumn 35, Issue 5, 2013, Pages 648-653

  Zhao, Jianxing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Chronic kidney disease; Kynurenic acid; Kynurenine; Plasma; Renal function; Tryptophan

Indexed keywords

CREATININE; KYNURENIC ACID; KYNURENINE; TRYPTOPHAN; UREA;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FUNCTIONAL ASSESSMENT; GLOMERULUS FILTRATION RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITAL PATIENT; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; HYPERTENSION; KIDNEY FUNCTION TESTS; KYNURENIC ACID; KYNURENINE; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; TRYPTOPHAN;

EID: 84877844695     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.790301     Document Type: Article

References (21)

1. Liu BC, Wu XC, Wang YL, et al. Investigation of the prevalence of CKDin 13,383 Chinese hospitalized adult patients. Clin Chim Acta. 2008;387:128-132
2. Filiopoulos V, Hadjiyannakos D, Vlassopoulos D. New insights into uric acid effects on the progression and prognosis of chronic kidney disease. Ren Fail. 2012;34:510-520
3. Cai F, Ren L, Liu H, et al. The relationship between the level of serum creatinine, modified diet and renal disease formula, Cockcroft-Gault formula, and renal tubulointerstitial lesion. Ren Fail. 2012;34:334-337
4. Robles NR, Mena C, Cidoncha J. Estimated glomerular filtration rate from serum cystatin C: Significant differences among several equations results. Ren Fail. 2012;34:871-875
5. Warnock DG, Muntner P, McCullough PA, et al. Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study. Am J Kidney Dis. 2010;56:861-871
6. Pawlak K, Kowalewska A, Mysliwiec M, Pawlak D. Kynurenine and its metabolites-kynurenic acid and anthranilic acid are associated with soluble endothelial adhesion molecules and oxidative status in patients with chronic kidney disease. Am J Med Sci. 2009;338:293-300
7. Saito K, Fujigaki S, Heyes MP, et al. Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency. Am J Physiol Renal Physiol. 2000;279:F565-F572
8. Pawlak K, Brzosko S, Mysliwiec M, Pawlak D. Kynurenine, quinolinic acid-The new factors linked to carotid atherosclerosis in patients with end-stage renal disease. Atherosclerosis. 2009;204:561-566
9. Schefold JC, Zeden JP, Fotopoulou C, et al. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: A possible link between chronic inflammation and uratemic symptoms. Nephrol Dial Transplant. 2009;24:1901-1908
10. Pawlak D, Tankiewicz A, Matys T, Buczko W. Peripheral distribution of kynurenine metabolites and activity of kynurenine pathway enzymes in renal failure. J Physiol Pharmacol. 2003;54:175-189 (Pubitemid 36781473)
11. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-S266
12. Xu B, Zhan Y, Gao P, Zhu D, Zhao J. Changes of plasma concentrations of tryptophan, kynurenine and kynurenic acid in essential hypertensive patients. Lab Med. 2012;27:624-627 (Chinese
13. Zhao J, Gao P, Zhu D. Optimization of Zn2-containing mobile phase for simultaneous determination of kynurenine, kynurenic acid and tryptophan in human plasma by high performance liquid chromatography. J Chromatogr B. 2010;878:603-608
14. Stoy N, Mackay GM, Forrest CM, et al. Tryptophan metabolism and oxidative stress in patients with Huntington's disease. J Neurochem. 2005;93:611-623 (Pubitemid 40617621)
15. Pawlak D, Tankiewicz A, Buczko W. Kynurenine and its metabolites in the rat with experimental renal insufficiency. J Physiol Pharmacol. 2001;52:755-766 (Pubitemid 34042360)
16. Holmes EW. Determination of serum kynurenine and hepatic tryptophan dioxygenase activity by high-performance liquid chromatography. Anal Biochem. 1988;172:518-525
17. Eleftheriadis T, Yiannaki E, Antoniadi G, et al. Plasma indoleamine 2,3-dioxygenase and arginase type I may contribute to decreased blood T-cell count in hemodialysis patients. Ren Fail. 2012;34:1118-1122
18. Eleftheriadis T, Antoniadi G, Liakopoulos V, Stefanidis I, Galaktidou G. Plasma indoleamine 2,3-dioxygenase concentration is increased in hemodialysis patients and may contribute to the pathogenesis of coronary heart disease. Ren Fail. 2012;34:68-72
19. Knox WE, Auerbach VH. The hormonal control of tryptophan peroxidase in the rat. J Biol Chem. 1955;214:307-313
20. Zhao J, Chen H, Ni P, et al. Simultaneous determination of urinary tryptophan, tryptophan-related metabolites and creatinine by high performance liquid chromatography with ultraviolet and fluorimetric detection. J Chromatogr B. 2011;879:2720-2725
21. Mason M. Kynurenine transaminase of rat kidney; a study of coenzyme dissociation. J Biol Chem. 1957;227:61-68